Unitedhealth's Stock Rallies on Improved Outlook for the Year

Dow Jones
07/16

The health insurance giant raised its profit guidance for the second time this year

UnitedHealth's medical-cost ratio in the second quarter came in lower than expected. (Photo by Patrick T. Fallon / AFP) (Photo by PATRICK T. FALLON/AFP via Getty Images)

UnitedHealth Group raised its earnings guidance for the second time this year in the latest signal that its business is returning to a better place.

The health insurance giant now expects adjusted net earnings of $19.50 to $20.00 per share in 2026. That's up from the more than $18.25 a share that the company guided for back in April and the $17.75 a share at the start of the year.

UnitedHealth's stock $(UNH)$ was up about 6.3 % in premarket trade on Thursday.

The company had revenue of $112.0 billion in the second quarter, up from $111.6 billion in the same three months of last year and beating the FactSet estimate of $110.8 billion.

It also said the medical-cost ratio - the percentage of health-insurance premiums that is spent on medical care - was 86.7% in the second quarter. That's far lower than the FactSet estimate of 88.4% and the 89.4% it reported in the second quarter of 2025. UnitedHealth's leadership attributed that improvement to "product design changes, improved medical management and better aligned pricing."

The company had 48.5 million customers in the second quarter, which again came in lower than the FactSet consensus of 51.0 million customers.

UnitedHealth's stock is up 24.4% so far this year, while the S&P 500 SPX has gained 10.4%.

-Jaimy Lee

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

July 16, 2026 06:08 ET (10:08 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10